Catherine Burzik Appointed Chair of VitaPath Genetics Board of Directors

Published: Sep 25, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--VitaPath Genetics, Inc., a privately held company leading the exploration of the Vitanome, the subset of information that lies within our genomes that plays a critical role in how we metabolize vitamins, today announced healthcare industry veteran Catherine Burzik has been appointed Chair of its Board of Directors.

Back to news